McGarry_2013_Adv.Biosci.Biotechnol_4_1020

Reference

Title : Evaluation of HemogloBind treatment for preparation of samples for cholinesterase analysis - McGarry_2013_Adv.Biosci.Biotechnol_4_1020
Author(s) : McGarry KG , Bartlett RA , Machesky NJ , Snider TH , Moyer RA , Yeung DT , Brittain MK
Ref : Adv Biosci Biotechnol , 4 :1020 , 2013
Abstract :

Acetylcholine is an essential neurotransmitter found throughout the nervous system. Its action on postsynaptic receptors is regulated through hydrolysis by various carboxylesterases, especially cholinesterases (ChEs). The acute toxicity of organophosphate (OP) compounds is directly linked to their action as inhibitors of ChE. One widely used assay for evaluating ChE activity is a spectrophotometric method developed by Ellman et al. When the enzyme source is from tissues or, in particular, blood, hemoglobin displays a spectrophotometric peak at the same wavelength used to analyze cholinergic activity. This creates a substantial background that interferes with the Ellman's assay and must be overcome in order to accurately monitor cholinesterase activity. Herein, we directly compare blood processing methods: classical method (1.67 +/- 0.30 U/mL) and HemogloBind treatment (1.51 +/- 0.17 U/mL), and clearly demonstrate that pretreatment of blood samples with Hemoglobind is both a sufficient and rapid sample preparation method for the assessment of ChE activity using the Ellman's method.

PubMedSearch : McGarry_2013_Adv.Biosci.Biotechnol_4_1020
PubMedID: 24749000

Related information

Citations formats

McGarry KG, Bartlett RA, Machesky NJ, Snider TH, Moyer RA, Yeung DT, Brittain MK (2013)
Evaluation of HemogloBind treatment for preparation of samples for cholinesterase analysis
Adv Biosci Biotechnol 4 :1020

McGarry KG, Bartlett RA, Machesky NJ, Snider TH, Moyer RA, Yeung DT, Brittain MK (2013)
Adv Biosci Biotechnol 4 :1020